HNL Lab Medicine Partners with Ibex to Bring AI Prostate Cancer Diagnostics to Its Labs
The Pennsylvania-based laboratory will integrate Ibex's AI solution for prostate biopsies and TURP specimens into its existing digital pathology infrastructure.
Category: Prostate
Prostate
Latest
Prostate
Latest
FDA Grants De Novo Authorization for AI-Powered Prostate Cancer Prognostic Software
The risk stratification tool is designed to predict long-term outcomes for patients with non-metastatic prostate cancer.
Prostate
Latest
Why Genomic Tests for Prostate Cancer Need Better Data
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read More
Why Men Should be Screened for the ‘Breast Cancer Gene’
Studies indicate men with BRCA1 and BRCA2 mutations face significant cancer risks, prompting new national screening guidelines.
Read More
Prostate Cancer Blood Test Equally Effective Across Ethnic Groups
A prostate cancer test using protein and genetic markers improves diagnosis accuracy and reduces unnecessary procedures across ethnic groups.
Read More
Prostate Cancer Risks for Transgender Women on Hormone Therapy
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read More
New Urine Test Detects High-Grade Prostate Cancer
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.
Read More
Blood Test Could Improve Active Surveillance for Prostate Cancer
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read More
Prostate Cancer Screening with a PSA Test Leads to OverdiagnosisÂ
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read More
Blood Test and MRI Combo Could Reduce Unnecessary Prostate Biopsies
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read More
Researchers Use Deep Learning to Diagnose Prostate Cancer
Researchers developed a deep-learning model to improve the 3D segmentation of glandular tissue structures for prostate cancer assessment.
Read More
AI Reveals Prostate Cancer is Not Just One Disease
AI has helped scientists reveal a new form of aggressive prostate cancer which could revolutionize how the disease is diagnosed in the future.Â
Read More
Oncobiomix Adopts AI-Based Disease Insights Platform for Prostate Cancer Test
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read More
AI Algorithm Promises to Improve Workflows at Ohio Cancer Center
Pathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read More
Rectal Examinations Do Not Improve Prostate Cancer Screening Effectiveness
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read More
Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancer
Researchers have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma.
Read More
ArteraAI Gets Medicare Payment Rate for Prostate Cancer Test
ArteraAI says the CMS decided on the payment rate for the ArteraAI Prostate Test, a clinical diagnostic laboratory test for prostate cancer.
Read More